Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. [electronic resource]
Producer: 20200224Description: 1595-1622 p. digitalISSN:- 1945-7197
- Absorptiometry, Photon
- Accidental Falls -- prevention & control
- Bone Density Conservation Agents -- therapeutic use
- Calcitonin -- therapeutic use
- Calcium -- therapeutic use
- Clinical Decision-Making
- Denosumab -- therapeutic use
- Diphosphonates -- therapeutic use
- Estrogen Receptor Modulators -- therapeutic use
- Estrogen Replacement Therapy
- Female
- Humans
- Norpregnenes -- therapeutic use
- Osteoporosis, Postmenopausal -- diagnostic imaging
- Osteoporotic Fractures -- prevention & control
- Parathyroid Hormone-Related Protein -- therapeutic use
- Patient Preference
- Raloxifene Hydrochloride -- therapeutic use
- Risk Assessment
- Risk Reduction Behavior
- Selective Estrogen Receptor Modulators -- therapeutic use
- Teriparatide -- therapeutic use
- Vitamin D -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.